Collins Laura C
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Surg Pathol Clin. 2018 Mar;11(1):177-197. doi: 10.1016/j.path.2017.09.007. Epub 2017 Dec 8.
The nonobligate precursor lesions columnar cell change/hyperplasia and flat epithelial atypia, atypical ductal hyperplasia and atypical lobular hyperplasia, lobular carcinoma in situ, and low-grade ductal carcinoma in situ share morphologic, immunophenotypic, and molecular features supporting the existence of a low-grade breast neoplasia pathway. The practical implication for pathologists is that the identification of one of these lesions should prompt careful search for others. From a clinical management perspective, however, their designation as "precursor lesions" should not be overemphasized, as the risk of progression among the earliest lesions is exceedingly low. Factors determining which lesions will progress remain unknown.
非必需性前驱病变柱状细胞改变/增生、扁平上皮异型增生、非典型导管增生和非典型小叶增生、小叶原位癌以及低级别导管原位癌具有形态学、免疫表型和分子特征,支持存在一条低级别乳腺肿瘤发生途径。对病理学家而言,实际意义在于识别出其中一种病变应促使仔细查找其他病变。然而,从临床管理角度来看,将它们认定为“前驱病变”不应被过度强调,因为最早病变进展的风险极低。决定哪些病变会进展的因素仍不清楚。